Table:
begin	end	state
1	11	cytoplasmic
12	26	non-cytoplasmic
27	41	transmembrane
42	49	non-cytoplasmic
50	71	transmembrane
72	81	cytoplasmic
82	101	transmembrane
102	106	non-cytoplasmic
107	127	transmembrane
128	147	cytoplasmic
148	171	transmembrane
172	182	non-cytoplasmic
183	202	transmembrane
203	240	cytoplasmic
241	258	transmembrane
259	277	non-cytoplasmic
278	295	transmembrane
296	306	cytoplasmic
307	326	transmembrane
327	330	non-cytoplasmic
331	351	transmembrane
352	362	cytoplasmic
363	385	transmembrane
386	397	non-cytoplasmic
398	419	transmembrane
420	447	cytoplasmic

Input:
>WP_110205269.1 NCBI__GCF_003194585.1:WP_110205269.1
MSTPTAPAVRRAIAASAIGNMTEWLDYGLYAYGVTYISAALFPGDTEQATLFALATFAIS
FLVRPLGGMFWGPLGDRVGRKAVLAVTILLMAGATLGVGLVPTYDRIGFWAPTLLVALRL
VQGFSTGGEYGGAATFMAEYAPDRRRGFLGSFLEFGTLTGFSLGALLMLGFSLALDDTAM
QAWGWRVPFLLAAPLGVIGLWLRSRAEDSPVFEEAAEERAVDEEPAVVRLRELVADHGRP
LLLLGALVMTLNVVNYTLLSYMPTYLEAEIGLSTDQSLMVPVIGMLTMMLFLPFAGHLSD
RVGRKPLWWVSVTGLFIAAVPMFLLMATGLLGAVIGFAVLGLLYVPQLATISSTFPAMFP
TQVRFAGFAIAYNVSTSLFGGTAPALNDWLVGLTGSALVPAFYMMLACAVGALALPAVVE
TAGVSLRGTEVPGTPESERELESLETT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server